Wednesday 12 November |
| 08:00-19:00 | | Registration Main Entrance
|
| 08:50-09:00 | | Welcome and Introduction by Dinesh Giri, CME Officer Main Hall
|
| 09:00-10:00 | | CME Symposium 1 Chair(s): Dinesh Giri (Bristol, UK) & Julie Park (Liverpool, UK) Main Hall
|
| 09:00 | CME 1.1 | Recent Advances in the Management of Pituitary Adenomas |
| 09:30 | CME 1.2 | An Approach to Endocrine Late Effects |
| 10:00-10:30 | | CME Case Presentations 1 & 2 Chair(s): Dinesh Giri (Bristol, UK) & Julie Park (Liverpool, UK) Main Hall
|
| 10:00 | OC1.1 | “Hidden in Plain Sight”: A Mini-Series of Diagnostic Difficulties in Paediatric Cushing’s Disease |
| 10:15 | OC1.2 | A Rare Case of Papillary Thyroid Carcinoma in a Child with a CDC73 Mutation |
| 10:30-11:00 | | Tea & Coffee Break Hadfield Hall
|
| 11:00-12:00 | | CME Sympsosium 2 Chair(s): Dinesh Giri (Bristol, UK) & Salma Ali (Glasgow, UK) Main Hall
|
| 11:00 | CME 2.1 | Recent Advances in the Management of Hypogonadotropic Hypogonadism |
| 11:30 | CME 2.2 | Adolescent Gynae for Paediatric Endocrinologist |
| 12:00-12:30 | | CME Case Presentations 3 & 4 Chair(s): Dinesh Giri (Bristol, UK) & Salma Ali (Glasgow, UK) Main Hall
|
| 12:00 | OC2.1 | Hyperparathyroidism, pseudohypoparathyroidism (PHP) or pseudopseudohypoparathyroidism (PPHP) – solving the GNAS riddle |
| 12:15 | OC2.2 | A rare case of heterozygous INSR variant presenting as hyperandrogenism in adolescence |
| 12:30-12:40 | | CSAC Trainee Representative Update Main Hall
|
| 12:40-13:30 | | Lunch and Exhibition Hadfield Hall
|
| 13:30-14:30 | | CME Symposium 3 Chair(s): Dinesh Giri (Bristol, UK) & Christina Wei (London, UK) Main Hall
|
| 13:30 | CME 3.1 | Update of Diabetes Transition Care - the International Consensus from ISPAD-ADA-EASD |
| 14:00 | CME 3.2 | Recent Advances in the Diagnosis and Management of Rare Diabetes |
| 14:30-15:00 | | CME Case Presentations 5 & 6 Chair(s): Dinesh Giri (Bristol, UK) & Christina Wei (London, UK) Main Hall
|
| 14:30 | OC3.1 | Teenage Kicks: The Complexity of an Adolescent living with Diabetes. Subcutaneous Insulin Resistance Syndrome (SIRS) or a Case of Induced Illness? |
| 14:45 | OC3.2 | A difficult diagnosis of B-ALL presenting with hypercalcaemia and multiple fractures |
| 15:00-15:30 | | Tea & Coffee Break Hadfield Hall
|
| 15:30-16:30 | | CME Symposium 4 Chair(s): Dinesh Giri (Bristol, UK) & Nadia Amin (Leeds, UK) Main Hall
|
| 15:30 | CME4.1 | An Approach to XX DSD |
| 16:00 | CME 4.2 | Talking to Children about Gender Identity and Sex Development |
| 16:30-16:45 | | CME Case Presentation 7 Chair(s): Dinesh Giri (Bristol, UK) & Nadia Amin (Leeds, UK) Main Hall
|
| 16:30 | OC4.1 | Diagnostic and phenotypic challenges in a rare case of 46, XX differences in sex development (DSD) with a heterozygous RSPO1 variant |
| 16:45-16:50 | | Update & Conclusion by Dinesh Giri Main Hall
|
| 17:00-17:45 | | Satellite Symposium For more information please see the satellite programme
|
| 18:00-19:00 | | Welcome reception Reception Room
|
Thursday 13 November |
| 08:00-18:30 | | Registration Main Entrance
|
| 08:00-08:45 | | Satellite Symposium For more information please see the satellite programme
|
| 09:00-09:10 | | Welcome and Introduction Chair(s): Renuka Dias (Birmingham, UK) & Paul Dimitri (Sheffield, UK) Main Hall
|
| 09:20-10:50 | | Endocrine Oral Communications 1 Chair(s): Zainaba Mohamed (Birmingham, UK) & Jarod Wong (Glasgow, UK) Main Hall
|
| 09:20 | OC5.1 | A novel polygenic risk prediction tool: improving the diagnosis of short stature |
| 09:30 | OC5.2 | Pilot Data from the I-HH Registry: Improving Management in Hypogonadotropic Hypogonadism |
| 09:40 | OC5.3 | Assessment of fetal growth trajectories and relationships with early infant adiposity at a single site within the UK Pregnancies Better Eating and Activity Trial (UPBEAT) |
| 09:50 | OC5.4 | Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma |
| 10:00 | OC5.5 | Comparison of electronic growth chart software reveals clinically relevant variability hindering growth assessment: A UK study |
| 10:10 | OC5.6 | Practice Patterns and Treatment Outcomes of Growth-Promoting Therapies in CAH: Insights from Real-World Data |
| 10:20 | OC5.7 | A multi-centre study of Adrenal Recovery in Children Tapering Corticosteroids (ARCTiC Study) |
| 10:30 | OC5.8 | The Effect of Letrozole on Bone Age Maturation and Estimated Adult Height in Patients with Congenital Adrenal Hyperplasia |
| 10:40 | | Presentation from Previous Award Winner |
| 09:20-10:50 | | CEW Symposium Chair(s): Senthil Senniappan (Liverpool, UK) & Dita Aswani (Sheffield, UK) Banqueting Hall
|
| 09:20 | | Current and future pharmacological therapy in weight management |
| 09:50 | | Diagnosis and management outside of pharmacological treatment |
| 10:20 | | Psychological Aspects of Living with Complications of Excess Weight |
| 09:20-10:00 | | PENS Annual Meeting Reception Room
|
| 10:00-10:25 | | PENS BSPED Prize Reception Room
|
| 10:25-10:50 | | PENS Nurse Presentation Reception Room
|
| 10:50-11:20 | | Tea & Coffee Break Hadfield Hall
|
| 10:50-11:20 | | Sanofi Training Station For more information, see the Industry Sponsored Training Stations page
|
| 11:20-12:20 | | Endocrine Symposium 1 Chair(s): Tim Cheetham (Newcastle, UK) & Anuja Natarajan (Sheffield, UK) Main Hall
|
| 11:20 | | Screening 100,000 Newborns Using Whole Genome Sequencing: The Generation Study |
| 11:40 | | The Management of Thyroid Nodules – Insights into Management in Childhood |
| 12:00 | | Innovative and novel therapies in Metabolic Bone Disease |
| 11:20-12:20 | | Diabetes Symposium 1 Chair(s): Neil Wright (Sheffield, UK) & Pooja Sachdev (Nottingham, UK) Banqueting Hall
|
| 11:20 | | Early detection of type 1 diabetes: staging and monitoring - a national approach and update |
| 11:40 | | Genetic Screening for Type 1 Diabetes and Primary Prevention Studies from GPADD |
| 12:00 | | Disease Modifying Therapy in Early T1D - Immunotherapy |
| 12:20-12:50 | | Endocrine Oral Communications 2 Chair(s): Dinesh Giri (Bristol, UK) & Claire Wood (Newcastle Upon Tyne, UK) Main Hall
|
| 12:20 | OC6.1 | Longitudinal evaluation of bone health index for assessment of bone health in Duchenne Muscular Dystrophy |
| 12:26 | OC6.2 | Retrospective Review of Remission and Relapse in Paediatric Graves’ Disease |
| 12:32 | OC6.3 | Evaluating Fibroscan as a screening tool for metabolic dysfunction-associated steatotic liver disease in children and young people with obesity |
| 12:38 | OC6.4 | Systematic reassessment of children with congenital hypothyroidism in North West England through development of a multi-centre clinical network of paediatricians |
| 12:44 | OC6.5 | Boys with Klinefelter syndrome referred to paediatric endocrine clinics have a much higher range of complexities than those in the community |
| 12:20-12:50 | | Diabetes Oral Communications 1 Chair(s): Aoife Kelleher (Leeds, UK) & Neil Wright (Sheffield, UK) Banqueting Hall
|
| 12:20 | OC7.1 | Revealing Metabolic Clues through the use of Continuous Glucose Monitoring |
| 12:26 | OC7.2 | A novel capillary-adjusted home oral glucose tolerance test: a practical and reliable alternative to the gold standard venous method in childhood early-stage type 1 diabetes |
| 12:32 | OC7.3 | A Quality Improvement Innovation to improve the early diagnosis of Type 1 Diabetes in Children and Young People in Wales: Has it made an impact? |
| 12:38 | OC7.4 | Fast-Tracking Success: Early Hybrid Closed Loop Initiation Dramatically Improves HbA1c in the First Year of Care in CYP with Type 1 Diabetes |
| 12:44 | OC7.5 | Efficacy and Safety of a Tubeless AID System Compared with MDI in Children and Adolescents with T1D in the RADIANT Study |
| 12:50-14:05 | | Lunch Hadfield Hall
|
| 12:50-13:20 | | Sanofi Training Station For more information, see the Industry Sponsored Training Stations page
|
| 13:05-13:50 | | Poster Tours Hadfield Hall
|
| 13:00-13:45 | | Satellite Symposium For more information please see the satellite programme
|
| 13:00-13:45 | | Satellite Symposium For more information please see the satellite programme
|
| 14:05-14:35 | | James M Tanner Award Main Hall
|
| 14:45-15:45 | | How Do I? Chair(s): Renuka Dias (Birmingham, UK) & Alaa Baioumi (Sheffield, UK) Main Hall
|
| 14:45 | | Menstrual Irregularities in the Adolescent |
| 15:15 | | Setmelanotide |
| 15:45-16:15 | | Tea & Coffee Break Hadfield Hall
|
| 15:45-16:00 | | Sandoz Training Station For more information, see the Industry Sponsored Training Stations page
|
| 16:15-16:45 | | Endocrine Oral Communications 3 Chair(s): Poonam Dharmaraj (Liverpool, UK) & Amanda Peacock (Newcastle Upon Tyne, UK) Main Hall
|
| 16:15 | OC8.1 | The Use of Medtech in Empowering Families within a Complications of Excess Weight Clinic: The Evira® App |
| 16:21 | OC8.2 | Genotype-endocrine phenotype associations in a large cohort of children with NF1 |
| 16:27 | OC8.3 | Quantification of 11-oxyandrogen biomarkers from dried blood spots using tandem mass spectrometry |
| 16:33 | OC8.4 | The IMPACT Survey in the UK: treatment patterns in osteogenesis imperfecta |
| 16:39 | OC8.5 | Evaluating the Predictive Utility of Basal Cortisol for Synacthen Test Outcomes in Neonates: A Retrospective Cohort Study |
| 16:15-17:15 | | Debate Chair(s): Zainaba Mohammed (Birmingham) Old Banqueting Hall
|
| | Use of growth hormone in idiopathic short stature (For) |
| | Use of growth hormone in idiopathic short stature (Against) |
| 17:30-18:30 | | BSPED's 2025 AGM Main Hall
|
| 19:30-23:59 | | Conference Dinner
|
Friday 14 November |
| 08:00-16:45 | | Registration Main Entrance
|
| 08:00-08:45 | | Satellite Symposium For more information please see the satellite programme
|
| 09:00-10:30 | | Diabetes Symposium 2 Chair(s): Astha Soni (Sheffield, UK) & Toby Candler (Bristol, UK) Main Hall
|
| 09:00 | | GIRFT and the NHS Diabetes Programme |
| 09:30 | | Lessons learned from the National Paediatric Diabetes Audit |
| 10:00 | | Grand Challenge |
| 09:00-10:30 | | Endocrine Symposium 2 (Nurses / Endocrine Professionals Session) Chair(s): Peter Laing (Liverpool, UK) & TBC Banqueting Hall
|
| 09:00 | | Use of GLP1 agonists in nurse led medication clinic |
| 09:20 | | The past, the present, and future of hypothalamic obesity |
| 09:40 | | Hypothalamic damage - grieving survival |
| 10:10 | | Panel Q&A |
| 10:30-11:00 | | Tea & Coffee Break Hadfield Hall
|
| 10:30-10:45 | | Sandoz Training Station For more information, see the Industry Sponsored Training Stations page
|
| 11:00-12:30 | | Diabetes Oral Communications 2 Chair(s): Fiona Regan (London, UK) & Rachel Besser (Oxford, UK) Main Hall
|
| 11:00 | OC9.1 | Developing a National Schools Training Platform Transforming Diabetes Awareness in Schools across the UK to meet the needs highlighted in the ‘The INSCHOOL' project |
| 11:10 | OC9.2 | Integrated, patient-centred, holistic transition model improves physical and psychosocial outcomes of young adults (16-25) with diabetes - Transition Safe and Sound (TraSS), an NHS England pilot. |
| 11:20 | OC9.3 | Reducing ‘Was Not Brought’ Rates in Paediatric Diabetes Clinic: Empowering Patient Choice to Improve Service Delivery |
| 11:30 | OC9.4 | Quantifying the effect of screening for childhood type 1 diabetes on HbA1c, DKA and hospitalisation at diagnosis: a systematic review and meta-analysis. |
| 11:40 | OC9.5 | Mind the Gap: Ongoing Inequalities in glycaemic levels in Young People living with Type 1 Diabetes across England and Wales |
| 11:50 | OC9.6 | Analysing the impact of socioeconomic deprivation and ethnicity on the development of vascular complications in young people with Type 1 Diabetes – A regional perspective |
| 12:00 | OC9.7 | A Phase II, International, Randomised, Double-blind, Efficacy and Safety Trial of Sodium Valproate in Paediatric and Adult Patients with Wolfram Syndrome. |
| 11:00-12:30 | | Endocrine Oral Communications 4 Chair(s): M Guftar Shaikh (Glasgow, UK) Banqueting Hall
|
| 11:00 | OC10.1 | Application of multi-omic approaches to investigate novel LZTR1 gene variants and identify therapeutic targets implicated in the pathogenesis of Noonan syndrome (NS) |
| 11:10 | OC10.2 | Iatrogenic Vitamin D toxicity within the Paediatric Population: An Acute Surge in National Cases |
| 11:20 | OC10.3 | The United Kingdom Adult NorthStar Network Consensus Recommendations of Transition of Osteoporosis Care and Management of Osteoporosis in Adults with Duchenne Muscular Dystrophy |
| 11:30 | OC10.4 | Pubertal Induction in girls with Turner syndrome: Updated retrospective data from the International TS Registry |
| 11:40 | | Break |
| 11:50 | OC10.5 | Assessing the Scale of the Teenage Obesity Epidemic in Northern Ireland: An audit of Prevalence and Practice in the Tertiary Paediatric Hospital |
| 12:00 | OC10.6 | “Real world” experience” of treatment with Wegovy (Semagluatide) and Saxenda (Liragluatide) in a Paediatric population living with Severe Obesity. |
| 12:10 | OC10.7 | Citizens Advice Sheffield (CAS) and Complications from Excess Weight (CEW) innovative integration pilot, recovering finances of over £29K for 31 families in initial 6 months. |
| 12:20 | OC10.8 | Behind the Glucose Dip: A Retrospective Review of Paediatric Ketotic Hypoglycaemia and Evolving Management Approaches |
| 12:30-12:50 | | Tea & Coffee Break Hadfield Hall
|
| 12:30-12:45 | | Sandoz Training Station For more information, see the Industry Sponsored Training Stations page
|
| 12:50-13:30 | | Plenary Chair(s): Verghese Mathew (Hull, UK) Main Hall
|
| 12:50 | | Navigating the role of paediatric endocrinology in young people’s gender services |
| 13:40-14:40 | | Lunch Hadfield Hall
|
| 13:40-14:10 | | Sanofi Training Station For more information, see the Industry Sponsored Training Stations page
|
| 13:45-14:30 | | Poster Tours
|
| 13:50-14:35 | | Satellite Symposium For more information please see the satellite programme
|
| 14:40-16:10 | | Diabetes Symposium 3 Chair(s): Nikki Davis (Southampton) & Billy White (London) Main Hall
|
| 14:40 | | Management of Type 2 - what’s coming to paediatrics |
| 15:10 | | Monogenic Diabetes - diagnostic pathways and insights into therapies |
| 15:40 | | Psychological aspects of T2D |
| 14:40-16:10 | | Endocrine Symposium 3 Chair(s): Elspeth Ferguson (Sheffield, UK) & Sanjay Gupta (Hull, UK) Banqueting Hall
|
| 14:40 | | Artificial Intelligence: Reimagining Growth and Pituitary Management |
| 15:10 | | An oncologist’s view of the management of late effects in paediatrics |
| 15:40 | | Innovations in the screening and diagnosis of adrenal insufficiency |
| 16:15-16:30 | | BSPED 2025 Awards Main Hall
|
| 16:30-16:45 | | Close of Meeting Main Hall
|